Mechanistic Insight Into Taxol-Induced Cell Death

Total Page:16

File Type:pdf, Size:1020Kb

Mechanistic Insight Into Taxol-Induced Cell Death Oncogene (2008) 27, 4580–4591 & 2008 Macmillan Publishers Limited All rights reserved 0950-9232/08 $30.00 www.nature.com/onc ORIGINAL ARTICLE Mechanistic insight into taxol-induced cell death F Impens1,2, P Van Damme1,2, H Demol1,2, J Van Damme1,2, J Vandekerckhove1,2 and K Gevaert1,2 1Department of Medical Protein Research, VIB, Ghent, Belgium and 2Department of Biochemistry, Ghent University, Ghent, Belgium We analysed the involvement of proteases during taxol- One class of chemotherapeutic drugs that induce such mediated cell death of human A549 non-small-cell lung alternative forms of PCD is microtubule-stabilizing carcinoma cells using a proteomics approach that specifi- agents with their prototypical representative taxol cally targets protein N termini and further detects newly (paclitaxel). Taxol and derivatives are used as potent formed N termini that are the result of protein processing. drugs against several solid tumors. Although their Our analysis revealed 27 protease-mediated cleavages, cytotoxic mechanism depends on cell type, concentra- which we divided in sites C-terminal to aspartic acid (Asp) tion and exposure duration, in most studies with and sites C-terminal to non-Aspresidues, as the result of clinically relevant taxol concentrations (10–200 nM), caspase and non-caspase protease activities, respectively. apoptosis is induced by blocking the mitotic spindle Remarkably, some of the former were insensitive to potent and a G2/M arrest (Schiff and Horwitz, 1980; Torres pancaspase inhibitors, and we therefore suggest that and Horwitz, 1998; Blagosklonny and Fojo, 1999; Zhao previous inhibitor-based studies that report on the caspase- et al., 2005). The signaling pathways leading to cell independent nature of taxol-induced cell death should be death have been extensively studied (Blagosklonny and judged with care. Furthermore, many of the sites C-terminal Fojo, 1999; Zhao et al., 2005) and recently several to non-Aspresidues were also uniquely observed in a model papers on the proteases involved were published. It is of cytotoxic granule-mediated cell death and/or found by now clear that taxol triggers apoptosis by both caspase- in vitro cataloging human l-calpain substrates using a dependent (Park et al., 2004; Ehrlichova et al., 2005; Li similar proteomics technique. This thus raises the hypothesis et al., 2005; Lu et al., 2005; Day et al., 2006; Janssen that killing tumor cells by chemotherapy or by immune cells et al., 2007; Pineiro et al., 2007) and caspase-indepen- holds similar non-Asp-specific proteolytic components with dent pathways (Broker et al., 2002, 2004; Huisman et al., strong indications to calpain activity. 2002; Ofir et al., 2002). One of the main supporting Oncogene (2008) 27, 4580–4591; doi:10.1038/onc.2008.96; observations for the latter is the failure of the published online 14April 2008 pancaspase inhibitor zVADfmk (N-benzyloxycarbonyl- Val-Ala-Asp(O-Me) fluoromethyl ketone) to protect Keywords: protease substrates; caspase-like activity; against taxol-induced apoptosis (Broker et al., 2002; taxol; cytotoxic granule Huisman et al., 2002). Here, we identified protease substrates targeted during taxol treatment of human A549 non-small-cell Introduction lung carcinoma cells using the peptide-centric proteo- mics technique known as N-terminal COFRADIC Chemotherapeutic agents kill tumor cells by different (COmbined FRActional DIagonal Chromatography). forms of programmed cell death (PCD). Next to This method specifically isolates (neo-)N-terminal pep- apoptosis with activation of the caspase cascade as the tides from digested proteomes before identification by most studied form, alternatives such as ‘apoptosis-like tandem mass spectrometry (Gevaert et al., 2003) and has PCD’ and ‘necrosis-like PCD’ have been described proven to be a powerful tool for substrate degradome (Leist and Jaattela, 2001). These modes of PCD are analysis (Lopez-Otin and Overall, 2002; Van Damme characterized by an essential activity of proteases other et al., 2005; Vande Walle et al., 2007): not only the than caspases during the onset or execution phase of cell protein substrates but also the exact cleavage sites death. For example, cathepsins (Foghsgaard et al., 2001; are simultaneously assigned, providing links to the Bidere et al., 2003; Broker et al., 2004), calpains functional implication of the cleavage events and to (Karmakar et al., 2007; Pineiro et al., 2007) and yet the type(s) of protease(s) creating the cleavage patterns. uncharacterized proteases (de Bruin et al., 2003) were reported to play key roles in different cell death models. Results Correspondence: Professor Dr K Gevaert, Department of Biochem- istry, Faculty of Medicine and Health Sciences, Ghent University, Treatment with taxol results in detachment and apoptosis A Baertsoenkaai 3, B-9000 Ghent, Belgium. E-mail: [email protected] of G2/M-arrested A549 cells Received 12 September 2007; revised 18 February 2008; accepted 5 Twenty-four hours after induction with 200 nM taxol, a March 2008; published online 14April 2008 fraction of A549 cells had detached from the culture Substrate degradomics of taxol-treated A549 cells F Impens et al 4581 dish and died during the next 24h, whereas a significant all parameters; however, the remarkable changes fraction of cells remained attached and did not show any between 24and 48h observed for detached cells as a apoptotic alterations, even after 48 h (Figure 1). Cell result of the execution phase of cell death are not cycle analysis by flow cytometry revealed that detach- present, pointing to stress conditions without triggering ment and associated cell death was the result of a mitotic cell death. Together, these observations clearly indicate arrest in the G2/M phase. This was not the case for the need to distinguish between detached and adherent adherent cells, where next to a limited increase in G2/M- A549 cell populations for further substrate degradomics. phase cells, a significant fraction of the cell population resided in other phases of the cell cycle (Figure 1). Besides the fact that the latter stopped dividing and that Lysosomal membrane permeabilization and activation stress granules were formed, no signs of PCD were of caspase-3 and calpains occur only in detached cells present. Next to caspases (Park et al., 2004; Ehrlichova et al., Time course flow cytometry experiments (Figure 2) 2005; Li et al., 2005; Lu et al., 2005; Day et al., 2006; further confirmed that detached cells were dying by Janssen et al., 2007; Pineiro et al., 2007), involvement of apoptosis, as a high proportion of these cells stained calpains (Pineiro et al., 2007) and cathepsin-B (Broker positive for annexin V and showed a hypoploid (sub- et al., 2004) was described in taxol-induced apoptosis. G1) DNA content at early time points (p24h). A large We compared taxol-treated detached and adherent fraction of these cells became positive for propidium A549 cells for activation of caspase-3 and calpains iodide (PI) only at late time points (X48 h). In adherent on immunoblots (Figure 3a). Lysosomal membrane cells, we measured a rather slow increase over time for permeabilization (LMP) and intracellular calcium control 24h 200 nM taxol 48h 200 nM taxol adherent cells adherent cells 1400 1400 1400 1120 1120 1120 840 G1 840 840 counts 560 S counts 560 counts 560 G2/M 280 280 sub-G1 280 0 0 0 100 101 102 103 104 100 101 102 103 104 100 101 102 103 104 red fluorescence red fluorescence red fluorescence detached cells detached cells 1400 1400 1120 1120 840 840 counts 560 counts 560 280 280 0 0 100 101 102 103 104 100 101 102 103 104 red fluorescence red fluorescence Figure 1 Taxol induces detachment and cell death of A549 cells suffering from mitotic arrest. Results of the analysis of the cell cycle by flow cytometry are shown as overlay histograms (open line) with control cells (filled line). Microscopic analysis revealed that detached cells are present after 24h taxol treatment and further die during the next 24h. In contrast to cells that remain adherent, detached cells are exclusively present in the G2/M phase of the cell cycle after 24h and show a high sub-G1 population after 48h, indicating cell death by apoptosis. Oncogene Substrate degradomics of taxol-treated A549 cells F Impens et al 4582 detached cells adherent cells not shown). Activation of the classical calpains (m- and m-calpain) was initiated 24h after taxol treatment and 100 was clearly visible after 48 h as shown by the formation of smaller autolytic fragments of the common small 75 calpain subunit (Wood and Newcomb, 1999). Flow cytometry revealed that the activation of calpains was accompanied by an increase of intracellular calcium 50 concentration. Finally, by measuring AO fluorescence, we observed LMP between 24and 48h in detached cells. 25 No evidence for the activation of proteases involved in cell death or LMP in adherent cells was obtained, in line with the fact that no PCD was observed in these 0 control 8h 16h24h 48h 72h cells (Figure 2). Based on these results, we screened for protease substrates in 48 h taxol-treated detached 100 A549 cells. 75 Screening by N-terminal COFRADIC in taxol-treated detached A549 cells identified 27 processed sites in 50 22 proteins Two proteomic screens were performed using N-terminal COFRADIC (Gevaert et al., 2003). In the % PI positive cells25 % annexin V positive cells first experiment, we post-metabolically labeled the 16 samples at the peptide level with light ( O2, control) 18 0 or heavy ( O2, taxol-treated) isotopes, introducing a control 8h 16h24h 48h 72h mass difference of 4Da (Staes et al., 2004). In the second 100 screen, cells were metabolically labeled during cell culture by SILAC (stable isotope labeling by amino 12 acids in cell culture) (Ong et al., 2002) with light ( C6, 75 13 taxol-treated) or heavy ( C6, control) arginine, introdu- cing a mass difference of 6 Da.
Recommended publications
  • An Sirna Screen Identifies RSK1 As a Key Modulator of Lung Cancer
    Oncogene (2011) 30, 3513–3521 & 2011 Macmillan Publishers Limited All rights reserved 0950-9232/11 www.nature.com/onc ORIGINAL ARTICLE An siRNA screen identifies RSK1 as a key modulator of lung cancer metastasis R Lara1,7, FA Mauri2, H Taylor3, R Derua4, A Shia3, C Gray5, A Nicols5, RJ Shiner2, E Schofield6, PA Bates6, E Waelkens4, M Dallman3, J Lamb3, D Zicha5, J Downward7, MJ Seckl1 and OE Pardo1 1Department of Oncology, Hammersmith Campus, Cyclotron Building, London, UK; 2Histopathology Imperial College London, Hammersmith Campus, London, UK; 3Division of Cell and Molecular Biology, Department of Life Sciences, Faculty of Natural Sciences, Imperial College London, London, UK; 4Labo Proteı¨ne Fosforylatie en Proteomics, Katholieke Universiteit Leuven, Leuven, Belgium; 5Light Microscopy Department, London Research Institute, London, UK; 6Biomolecular Modelling Laboratory, London Research Institute, London, UK and 7Signal Transduction Laboratory, Cancer Research UK, London Research Institute, London, UK We performed a kinome-wide siRNA screen and identified Introduction 70 kinases altering cell migration in A549 lung cancer cells. In particular, ribosomal S6 kinase 1 (RSK1) Lung cancer is the most common cancer killer with silencing increased, whereas RSK2 and RSK4 down- a 5-year survival rate o5%. Non-small cell lung cancer regulation inhibited cell motility. In a secondary collagen- (NSCLC) accounts for 80% of cases of which adeno- based three-dimensional invasion screen, 38 of our hits carcinoma represents the majority. Most patients cross-validated, including RSK1 and RSK4. In two further present with metastatic lesions and are incurable. Hence, lung cancer cell lines, RSK1 but not RSK4 silencing a better understanding of the biological processes showed identical modulation of cell motility.
    [Show full text]
  • Development of Carbon Dots As Fluorescent Probes for Fluorescence in Situ Hybridisation (FISH) Application
    Development of Carbon Dots as Fluorescent Probes for Fluorescence In Situ Hybridisation (FISH) Application By Phyllis Jacqueline Nishi A thesis submitted to the Faculty of Engineering, Computing and Science Swinburne University of Technology Sarawak In fulfilment of the requirements for the degree of Master of Science by Research 2019 Abstract Fluorescence in situ hybridisation (FISH) is an important bioimaging technique in molecular cytogenetics that utilises fluorescent probes that can bind specifically to a target nucleic acid sequence of a DNA or RNA. It is important that the fluorophores used to fluorescently tag probes are bright, small-sized, non-toxic and come in various colours. Thus, there is a need for new and alternative fluorescent labels to be developed to improve the performance of FISH. This thesis explores on the synthesis and application of carbon dots (CDs) as a class of versatile fluorescent label in FISH. The synthetic method for the production of CDs for use as fluorescent probes in FISH was described. CDs were synthesised by hydrothermal treatment of a carbon source in concentrated phosphoric acid solution. In this work, carboxymethylcellulose (CMC) was selected as the starting precursor and then converted into CDs with carboxylic functional groups. The optical properties and characterisation of the synthesised CDs were carried out. An amine-functionalised oligonucleotide probe was designed to detect and localise glyceraldehyde 3-phosphate dehydrogenase (GAPDH) mRNA in human adult low calcium high temperature keratinocytes (HaCaT) cell line. CDs were neutralised, isolated and dried before conjugated with the GAPDH oligonucleotide probe via carbodiimide crosslinker chemistry. The conjugated CD-GAPDH probe were applied for in situ hybridisation in fixed HaCaT cell line.
    [Show full text]
  • Download the Book of Poster Abstracts
    500 Combined administration of insulin and leptin significantly increased Fos production in the arcuate nucleus and renal sympathetic nerve activity Hamza Habeeballah1, Naif Alsuhaymi1, Martin Stebbing1, Trisha Jenkins1, Emilio Badoer1. School of Health and Biomedical Sciences, RMIT University, Melbourne, Vic. Introduction. Leptin has sympatho-excitatory effects on renal sympathetic nerve activity (RSNA). Insulin also induces increases in RSNA. There is considerable interest in the central actions of leptin and insulin on sympatho-excitation. The brain regions mediating insulin’s effects are unclear, compared to leptin. Aims. This study (i) investigated whether leptin and insulin together elicits greater increases in renal sympathetic nerve activity (RSNA), mean arterial pressure (MAP) and heart rate (HR) than when given alone, and (ii) quantified the number of activated neurons in brain regions influencing SNA, to identify potential central sites of interaction. Methods. Anesthesia of Male Sprague-Dawley rats was induced with isoflurane (2-5%) in O2 and maintained with intravenous urethane (1.4-1.6 g/kg). RSNA, MAP and HR were recorded prior to and for 3 hours following intracerebroventricular (ICV) saline (control; n=5), leptin (7 μg; n=5), insulin (500 mU; n=4) and the combination (leptin administered 15 minutes after insulin; n=4). Results Following leptin or insulin alone, RSNA was significantly increased (74% and 62% respectively), but together, the RSNA increase (124%) was significantly greater than either alone. Insulin alone increased HR significantly but this was prevented by leptin. MAP was not significantly different between groups. Only in the arcuate nucleus did leptin and insulin together increase the number of Fos-positive cell nuclei significantly more than the increases following leptin or insulin alone.
    [Show full text]
  • Response to Microtubule-Interacting Agents in Primary Epithelial Ovarian Cancer Cells
    Pellicciotta et al. Cancer Cell International 2013, 13:33 http://www.cancerci.com/content/13/1/33 PRIMARY RESEARCH Open Access Response to microtubule-interacting agents in primary epithelial ovarian cancer cells Ilenia Pellicciotta1, Chia-Ping Huang Yang2,3, Charis A Venditti4, Gary L Goldberg2 and Shohreh Shahabi2,4* Abstract Background: Ovarian cancer constitutes nearly 4% of all cancers among women and is the leading cause of death from gynecologic malignancies in the Western world. Standard first line adjuvant chemotherapy treatments include Paclitaxel (Taxol) and platinum-based agents. Taxol, epothilone B (EpoB) and discodermolide belong to a family of anti-neoplastic agents that specifically interferes with microtubules and arrests cells in the G2/M phase of the cell cycle. Despite initial success with chemotherapy treatment, many patients relapse due to chemotherapy resistance. In vitro establishment of primary ovarian cancer cells provides a powerful tool for better understanding the mechanisms of ovarian cancer resistance. We describe the generation and characterization of primary ovarian cancer cells derived from ascites fluids of patients with epithelial ovarian cancer. Methods: Chemosensitivity of these cell lines to Taxol, EpoB and discodermolide was tested, and cell cycle analysis was compared to that of immortalized ovarian cancer cell lines SKOV3 and Hey. The relationship between drug resistance and αβ-tubulin and p53 status was also investigated. Results: All newly generated primary cancer cells were highly sensitive to the drugs. αβ-tubulin mutation was not found in any primary cell lines tested. However, one cell line that harbors p53 mutation at residue 72 (Arg to Pro) exhibits altered cell cycle profile in response to all drug treatments.
    [Show full text]
  • Down-Regulation of Tensin2 Enhances Tumorigenicity and Is Associated with a Variety of Cancers
    www.impactjournals.com/oncotarget/ Oncotarget, Vol. 7, No. 25 Research Paper Down-regulation of tensin2 enhances tumorigenicity and is associated with a variety of cancers Shiao-Ya Hong1,*, Yi-Ping Shih1,*, Peng Sun1, Wang-Ju Hsieh1, Wen-Chang Lin2, Su Hao Lo1 1Department of Biochemistry and Molecular Medicine, University of California-Davis, Sacramento, CA 95817, USA 2Institute of Biomedical Sciences, Academia Sinica, Taipei 115, Taiwan *These authors have contributed equally to this work Correspondence to: Su Hao Lo, e-mail: [email protected] Keywords: tensin, IRS1, Mek, focal adhesion, tumorigenesis Received: January 4, 2016 Accepted: April 28, 2016 Published: May 17, 2016 ABSTRACT Tensin family members, including tensin2 (TNS2), are present as major components of the focal adhesions. The N-terminal end of TNS2 contains a C1 region (protein kinase C conserved region 1) that is not found in other tensin members. Three isoforms of TNS2 have been identified with previous reports describing the shortest V3 isoform as lacking the C1 region. Although TNS2 is known to regulate cell proliferation and migration, its role in tumorigenicity is controversial. By gain-of- function overexpression approaches, results supporting either promotion or reduction of cancer cell tumorigenicity were reported. Here we report that the complete V3 isoform also contains the C1 region and describe the expression patterns of the three human TNS2 isoforms. By loss-of-function approaches, we show that silencing of TNS2 up-regulates the activities of Akt, Mek, and IRS1, and increases tumorigenicities in A549 and Hela cells. Using public database analyses we found that TNS2 is down- regulated in head and neck, esophageal, breast, lung, liver, and colon cancer.
    [Show full text]
  • Endophytes from Australian Native Plants As Novel Sources of Bioactive Compounds for Industrial, Environmental and Medicinal Applications
    Endophytes from Australian native plants as novel sources of bioactive compounds for industrial, environmental and medicinal applications A thesis submitted in fulfilment of the requirements for the degree of Doctor of Philosophy By Bita Zaferanloo Department of Chemistry & Biotechnology, School of Science, Faculty of Science, Engineering and Technology Swinburne University of Technology, Australia March 2014 Abstract Natural products, including endophytic fungi, have received increased interest over the past decade for their therapeutic potential. Endophytes are fungi (or bacteria) which live in the intercellular spaces of plant tissues, for all or part of their lifecycle. The endophyte-plant relationship is symbiotic and it is believed that endophytic fungi live mutualistically with the host plant with no apparent symptoms. The asymptomatic nature of these fungi demonstrates enormous diversity and abundance, with nearly 30,000 land plant species in symbiosis with a multitude of species of endophytes. The ability of these microorganisms to colonize host plants in extreme, specialized environments has seen the development of complex relationships forming between endophyte and host. This subsequently increases the fitness of both plant and endophyte by the adaptive evolution of specialised survival mechanisms. It is suggested that these fungal endophytes offer a potentially enormous source of novel bioactive compounds that could be useful in medicine and other diverse applications, including industry and environment. In this work, the antibacterial, anticancer and enzyme activities of endophytic fungi from two Australian native plants Eremophila longifolia and E. maculata were investgiated. The rationale behind this search for new bioactive compounds and effective enzymes was based on the result of accumulated knowledge collected by indigenous Australians about the potentially medicinal properties of these two Australian native plants.
    [Show full text]
  • Effect of A549 Neuroendocrine Differentiation on Cytotoxic Immune Response
    ID: 18-0145 7 5 I Mendieta et al. Lung cancer NED effect over 7:5 791–802 CTLs response RESEARCH Effect of A549 neuroendocrine differentiation on cytotoxic immune response Irasema Mendieta1, Rosa Elvira Nuñez-Anita2, Gilberto Pérez-Sánchez3, Lenin Pavón3, Alfredo Rodríguez-Cruz1, Guadalupe García-Alcocer1 and Laura Cristina Berumen1 1Facultad de Química, Universidad Autónoma de Querétaro, Querétaro, Mexico 2Facultad de Medicina Veterinaria y Zootecnia, Universidad Michoacana de San Nicolás Hidalgo, Morelia, Michoacán, Mexico 3Departmento de Psicoimunología, Instituto Nacional de Psiquiatría Ramón de la Fuente Muñiz, Ciudad de México, Mexico Correspondence should be addressed to L C Berumen: [email protected] Abstract The present study was designed to determine the effects of factors secreted by the Key Words lung adenocarcinoma cell line with the neuroendocrine phenotype, A549NED, on f lung cancer cytotoxic T lymphocytes (CTLs) activity in vitro. A perspective that integrates the f neuroendocrine tumours nervous, endocrine and immune system in cancer research is essential to understand f neuroendocrine the complexity of dynamic interactions in tumours. Extensive clinical research suggests differentiation that neuroendocrine differentiation (NED) is correlated with worse patient outcomes; f transdifferentiation however, little is known regarding the effects of neuroendocrine factors on the f antitumour response communication between the immune system and neoplastic cells. The human lung f immunomodulator cancer cell line A549 was induced to NED (A549NED) using cAMP-elevating agents. The A549NED cells showed changes in cell morphology, an inhibition of proliferation, an overexpression of chromogranin and a differential pattern of biogenic amine production (decreased dopamine and increased serotonin [5-HT] levels). Using co-cultures to determine the cytolytic CTLs activity on target cells, we showed that the acquisition of NED inhibits the decrease in the viability of the target cells and release of fluorescence.
    [Show full text]
  • Microarray Expression Profile of Long Non-Coding Rnas in Paclitaxel-Resistant Human Lung Adenocarcinoma Cells
    ONCOLOGY REPORTS 38: 293-300, 2017 Microarray expression profile of long non-coding RNAs in paclitaxel-resistant human lung adenocarcinoma cells XIN TIAN1,2, HONGYAN ZHANG1, BIJUN ZHANG1, JIANZHU ZHAO1, TINGTING LI1 and YANYAN ZHAO1 Departments of 1Clinical Genetics and 2Medical Oncology, Shengjing Hospital of China Medical University, Shenyang, Liaoning 110004, P.R. China Received October 20, 2016; Accepted May 15, 2017 DOI: 10.3892/or.2017.5691 Abstract. Paclitaxel (PTX)-based chemotherapy is a standard Introduction treatment for human lung adenocarcinoma, but treatment often fails since resistance develops. Recent studies have described Lung cancer is one of the most common human cancers, the activity of long non-coding RNAs (lncRNAs) in many and with the highest worldwide incidence and mortality (1). biological processes and human diseases. Chemotherapy resis- Adenocarcinoma is one of the more common pathological tance is one of these areas, but the role of lncRNAs in paclitaxel types (2). Despite advances in surgery, radiotherapy and resistance of human lung adenocarcinoma cells has not been targeted treatment, survival is far from satisfactory. Most reported. A paclitaxel resistance model was established patients are given paclitaxel (PTX)-based combination chemo- using A549 human lung adenocarcinoma cells. lncRNAs and therapy as a standard treatment (3). Paclitaxel is a taxane, and mRNAs were profiled in parental A549 and paclitaxel-resistant its cytotoxic effect depends on microtubule polymerization, A549/PTX cells by microarray analysis. Real-time quantita- and inhibition of microtubule depolymerization leads to a cell tive PCR (RT-qPCR) was used to validate the results of the cycle block in the G2/M phase resulting in tumor cell apoptosis microarray.
    [Show full text]
  • A Mirna-200C/Cathepsin L Feedback Loop Determines Paclitaxel Resistance in Human Lung Cancer A549 Cells in Vitro Through Regulating Epithelial–Mesenchymal Transition
    Acta Pharmacologica Sinica (2018) 39: 1034–1047 © 2018 CPS and SIMM All rights reserved 1671-4083/18 www.nature.com/aps Article A miRNA-200c/cathepsin L feedback loop determines paclitaxel resistance in human lung cancer A549 cells in vitro through regulating epithelial–mesenchymal transition Yi-fan ZHAO1, #, Mei-ling HAN1, 2, #, Ya-jie XIONG1, Long WANG1, Yao FEI1, Xiao SHEN1, Ying ZHU1, Zhong-qin LIANG1, * 1Department of Pharmacology, College of Pharmaceutical Sciences, Soochow University, Suzhou 215123, China; 2Department of Pharmacy, Wuxi Children’s Hospital, Wuxi 214013, China Abstract Cathepsin L (CTSL), a cysteine protease, is closely related to tumor occurrence, development, and metastasis, and possibly regulates cancer cell resistance to chemotherapy. miRNAs, especially the miR-200 family, have been implicated in drug-resistant tumors. In this study we explored the relationship of CTSL, miRNA-200c and drug resistance, and the potential regulatory mechanisms in human lung cancer A549 cells and A549/TAX cells in vitro. A549/TAX cells were paclitaxel-resistant A549 cells overexpressing CTSL and characterized by epithelial-mesenchymal transition (EMT). We showed that miRNA-200c and CTSL were reciprocally linked in a feedback loop in these cancer cells. Overexpression of miRNA-200c in A549/TAX cells decreased the expression of CTSL, and enhanced their sensitivity to paclitaxel and suppressed EMT, whereas knockdown of miRNA-200c in A549 cells significantly increased the expression of CTSL, and decreased their sensitivity to paclitaxel and induced EMT. Overexpression of CTSL in A549 cells significantly decreased the expression of miRNA-200c, and reduced their sensitivity to paclitaxel and induced EMT, but these effects were reversed by miRNA-200c, whereas knockdown of CTSL in A549/TAX cells attenuated paclitaxel resistance and remarkably inhibited EMT, but the inhibition of miRNA-200c could reverse these effects.
    [Show full text]
  • Taxol®) in Human Tumour Cell Lines
    Br. J. Cancer 1104-1109 Macmillan Press 1993 Macmillan Press Ltd., Br. J. Cancer (1993), 68, 1104 1109 © Cytotoxic studies of pacfitaxel (Taxol®) in human tumour cell lines J.E. Liebmann, J.A. Cook, C. Lipschultz, D. Teague, J. Fisher, & J.B. Mitchell Radiation Oncology Branch, Building 10, Room B3B69, National Cancer Institute, Bethesda, Maryland 20892, USA. Summary The cytotoxicity of paclitaxel against eight human tumour cell lines has been studied with in vitro clonogenic assays. The fraction of surviving cells fell sharply after exposure for 24 h to paclitaxel concentra- tions ranging from 2 to 20 nM; the paclitaxel IC50 was found to range between 2.5 and 7.5 nM. Increasing the paclitaxel concentration above 50 nm, however, resulted in no additional cytotoxicity after a 24 h drug exposure. Cells incubated in very high concentrations of paclitaxel (10,000 nM) had an increase in survival compared with cells treated with lower concentrations of the drug. Prolonging the time of exposure of cells to paclitaxel from 24 to 72 h increased cytotoxicity from 5 to 200 fold in different cell lines. Exponentially growing cells were more sensitive to paclitaxel than were cells in the plateau phase of growth. Cremophor EL, the diluent in which the clinical preparation of paclitaxel is formulated, antagonised paclitaxel at concentra- tions of 0.135% (v/v). These data suggest that paclitaxel will be most effective clinically when there is prolonged exposure of tumour to the drug. Further, it appears that modest concentrations (i.e., 50 nM) should be as effective as higher concentrations of paclitaxel.
    [Show full text]
  • As a Cisplatin-Sensitizing Therapeutic Target
    Author Manuscript Published OnlineFirst on August 8, 2017; DOI: 10.1158/1078-0432.CCR-17-0700 Author manuscripts have been peer reviewed and accepted for publication but have not yet been edited. In Vivo Validation of PAPSS1 (3’-phosphoadenosine 5’-phosphosulfate synthase 1) as a Cisplatin-Sensitizing Therapeutic Target Ada W. Y. Leunga,b, Chansey J. Veinottec, Nicole Melongc, Min Hee Ohd,e, Kent Chena,e, Katey S. S. Enfieldd, Ian Backstroma, Corinna Warburtona, Donald Yappa,f, Jason N. Bermanc,g, Marcel B. Ballya,b,f,h, and William W. Lockwoodb,d,e aExperimental Therapeutics, BC Cancer Research Centre, Vancouver, BC, V5Z 1L3, Canada bDepartment of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, BC, V6T 2B5, Canada cDepartment of Pediatrics, Dalhousie University/IWK Health Centre, PO Box 9700, 5850/5980 University Avenue, Halifax, NS, B3K 6R8, Canada dIntegrative Oncology, BC Cancer Agency, Vancouver, BC, V5Z 1L3, Canada. eThe Interdisciplinary Oncology Program, University of British Columbia, Vancouver, BC, V5Z 4S6, Canada fFaculty of Pharmaceutical Sciences, University of British Columbia, Vancouver, BC, V6T 1Z3, Canada g Department of Microbiology & Immunology and Pathology, Life Sciences Research Institute, Faculty of Medicine, Dalhousie University, 1348 Summer Street, Halifax, NS, B3H 4R2, Canada. hCentre for Drug Research and Development, Vancouver, BC, V6T 1Z3, Canada Running Title: PAPSS1 as a Cisplatin-Sensitizing Therapeutic Target Keywords: PAPSS1, cisplatin, chemosensitization, combination chemotherapy, target validation Financial Support: The work presented was funded by the Canadian Institutes of Health Research (CIHR; MOP 89948 and PJT-148725), and the zebrafish studies were completed with financial support from the Centre for Drug Research and Development (CDRD).
    [Show full text]
  • 2013 Virtual Book
    23rd Annual RESEARCH DAY FRIDAY, FEBRUARY 22, 2013 TABLE OF CONTENTS Research Day 2013 Agenda................................................................................................ 3 Letter from the Associate Vice President, USF Health Office of Research .......................... 5 Sponsors ............................................................................................................................. 6 Roy H. Behnke Distinguished Lectureship .......................................................................... 7 Keynote Speaker Bio ........................................................................................................... 8 Administration ...................................................................................................................... 9 USF Health Research Committee Rosters ........................................................................ 10 Staff Acknowledgements ................................................................................................... 13 Posterboard Information .................................................................................................... 15 Listing of Presenters and Titles ......................................................................................... 16 Category Listing ................................................................................................................. 34 4thAnnual Joseph Krzanowski, PhD, USF Health Invited Oral Presentations Session ...... 35 Abstract Poster Presentation
    [Show full text]